Literature DB >> 15902537

Occurrence and regional distribution of SHV-type extended-spectrum beta-lactamases in Hungary.

A Tóth1, M Gacs, K Márialigeti, G Cech, M Füzi.   

Abstract

In order to determine the presence and geographical distribution of SHV-type extended-spectrum beta-lactamase genes among Enterobacteriaceae strains in Hungary, isolates from 25 microbiology laboratories throughout the country were collected between January 2002 and August 2003 and examined. Sequencing of the genes showed that SHV-5 and SHV-2a are the dominant SHV-types in extended-spectrum beta-lactamase-producing Enterobacteriaceae strains in this country. The SHV-2 gene, which is prevalent in many European countries, was not detected, but one isolate carried the SHV-12 gene. The results show that these genes are circulating among Enterobacteriaceae strains in Hungary and indicate that strict infection control measures are warranted in order to prevent their spread.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15902537     DOI： 10.1007/s10096-005-1315-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  15 in total

1.  Molecular epidemiology of a cluster of cases due to Klebsiella pneumoniae producing SHV-5 extended-spectrum beta-lactamase in the premature intensive care unit of a Hungarian hospital.

Authors:  D Szabó; Z Filetóth; J Szentandrássy; M Némedi; E Tóth; C Jeney; G Kispál; F Rozgonyi
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Molecular characterization of extended-spectrum beta-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey.

Authors:  Mariagrazia Perilli; Emanuela Dell'Amico; Bernardetta Segatore; Maria Rosaria de Massis; Ciro Bianchi; Francesco Luzzaro; Gian Maria Rossolini; Antonio Toniolo; Giuseppe Nicoletti; Gianfranco Amicosante
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

3.  Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes.

Authors:  E Tzelepi; P Giakkoupi; D Sofianou; V Loukova; A Kemeroglou; A Tsakris
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

4.  Complex endemic situation regarding extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a hospital in Slovenia.

Authors:  Borut Jutersek; Anna Baraniak; Tjasa Zohar-Cretnik; Alenka Storman; Ewa Sadowy; Marek Gniadkowski
Journal:  Microb Drug Resist       Date:  2003       Impact factor: 3.431

5.  Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 beta- lactamase: parallel outbreaks due to multiple plasmid transfer.

Authors:  W M Prodinger; M Fille; A Bauernfeind; I Stemplinger; S Amann; B Pfausler; C Lass-Florl; M P Dierich
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

6.  Characterization of the extended-spectrum beta-lactamases and determination of the antibiotic susceptibilities of Klebsiella pneumoniae isolates in Hungary.

Authors:  Z Pragai; Z Koczian; E Nagy
Journal:  J Antimicrob Chemother       Date:  1998-09       Impact factor: 5.790

7.  Survey and molecular genetics of SHV beta-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12.

Authors:  M T Nüesch-Inderbinen; F H Kayser; H Hächler
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

8.  Molecular epidemiology of extended-spectrum beta-lactamases from Klebsiella pneumoniae strains isolated in Zagreb, Croatia.

Authors:  B Bedenić; C C Randegger; E Stobberingh; H Hächler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-07       Impact factor: 3.267

Review 9.  Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control.

Authors:  Enno Stürenburg; Dietrich Mack
Journal:  J Infect       Date:  2003-11       Impact factor: 6.072

10.  Outbreak of ceftazidime-resistant Klebsiella pneumoniae in a pediatric hospital in Warsaw, Poland: clonal spread of the TEM-47 extended-spectrum beta-lactamase (ESBL)-producing strain and transfer of a plasmid carrying the SHV-5-like ESBL-encoding gene.

Authors:  M Gniadkowski; A Palucha; P Grzesiowski; W Hryniewicz
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191
View more
  5 in total

1.  Application of minimal sequence quality values prevents misidentification of the blaSHV type in single bacterial isolates carrying different SHV extended-spectrum beta-lactamase genes.

Authors:  Nashwan Al Naiemi; Kim Schipper; Birgitta Duim; Aldert Bart
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

2.  Dissemination of ST274 Klebsiella pneumoniae epidemic clone in newborn and adult hospital settings harbouring SHV-2A or CTX-M-15 type extended spectrum β-lactamases-producing known plasmids.

Authors:  I Damjanova; A Tóth; E Kenesei; M Köhalmi; P Szántai; M Füzi; J Pászti
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-09-09

3.  Extended-spectrum beta-lactamase-producing Klebsiella spp. in a neonatal intensive care unit: risk factors for the infection and the dynamics of the molecular epidemiology.

Authors:  K Kristóf; D Szabó; J W Marsh; V Cser; L Janik; F Rozgonyi; A Nobilis; K Nagy; D L Paterson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-08       Impact factor: 3.267

4.  Fitness cost associated with resistance to fluoroquinolones is diverse across clones of Klebsiella pneumoniae and may select for CTX-M-15 type extended-spectrum β-lactamase.

Authors:  A Tóth; B Kocsis; I Damjanova; K Kristóf; L Jánvári; J Pászti; R Csercsik; J Topf; D Szabó; P Hamar; K Nagy; M Füzi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-12-04       Impact factor: 3.267

5.  Imported PER-1 producing Pseudomonas aeruginosa, PER-1 producing Acinetobacter baumanii and VIM-2-producing Pseudomonas aeruginosa strains in Hungary.

Authors:  Dora Szabó; Julia Szentandrássy; Zsuzsa Juhász; Katalin Katona; Károly Nagy; László Rókusz
Journal:  Ann Clin Microbiol Antimicrob       Date:  2008-05-30       Impact factor: 3.944
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.